The Centers for Disease Control and Prevention (CDC) is notifying clinicians and public health authorities of an increase in Oropouche virus disease in the Americas region, originating from endemic areas in the Amazon basin and new areas in South America and the Caribbean.
Between January 1 and August 1, 2024, more than 8,000 cases of Oropouche virus disease were reported, including two deaths and five cases of vertical transmission associated with fetal death or congenital abnormalities. Countries reporting cases include Brazil, Bolivia, Peru, Colombia, and Cuba. In the United States and Europe in 2024, travel-associated cases have been identified in travelers returning from Cuba and Brazil. As testing and surveillance for Oropouche virus disease increase in the Americas, reports of cases from additional countries are expected.
This CDC Health Advisory includes recommendations for healthcare providers on the diagnosis and management of Oropouche virus disease, the risk of vertical transmission, and prevention strategies.
In addition, the CDC has released the following guidance for healthcare providers:
